Atovaquone-HSA nano-drugs enhance the efficacy of PD-1 blockade immunotherapy by alleviating hypoxic tumor microenvironment.
J Nanobiotechnology
; 19(1): 302, 2021 Oct 02.
Article
in En
| MEDLINE
| ID: mdl-34600560
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Atovaquone
/
Nanoparticles
/
Tumor Microenvironment
/
Programmed Cell Death 1 Receptor
/
Tumor Hypoxia
Limits:
Animals
Language:
En
Journal:
J Nanobiotechnology
Year:
2021
Type:
Article